|
|
8/08/16
|
Symic Bio has agreed to a long-term expansion/relocation lease for 24.4k sf of office/biotech lab space in Emeryville. The firm, which develops compounds for a variety of therapeutic areas, is relocating from San Franciso.
Currently operating in just a few thousand square feet of incubator space in San Francisco’s Dogpatch neighborhood, the fast-growing clinical-stage biotherapeutics company will be moving into a multi-story Class A building known as EmeryStation North, located at 5858 Horton St. Owned by Wareham Development, the building is part of a larger mixed-use, transit-oriented campus that serves home to other life science tenants such as Nanomix, Inc., Novartis, and NovaBay Pharmaceutical.
Symic is scheduled to move to its new Emeryville space later this year. They were repped in the deal by Chris Johnke, Cameron Love, Cale Miller, Erich Sollman, Gabe Burke, Dan Latini, and Steven Gargiulo with Cushman & Wakefield’s San Francisco office.
|
|
 Return to the Archive page
|
|
|
|
|
Printer-friendly Version
Email an Associate